Influence of initial biopsy technique on the ability to identify sentinel nodes in breast cancer patients [2]

Breast Journal

Volumn 11, Issue 3, 2005, Pages 224-

  Jablon, Lisa K ^a   Namjoshi, Smita D ^a   Braitman, Leonard E ^a   Somers, Robert G ^a  

^a ALBERT EINSTEIN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ISOSULFAN BLUE;

ANAMNESIS; BREAST CANCER; CANCER DIAGNOSIS; CANCER STAGING; CANCER SURGERY; DIAGNOSTIC ACCURACY; HUMAN; LETTER; MAMMOGRAPHY; RETROSPECTIVE STUDY; SENTINEL LYMPH NODE; SENTINEL LYMPH NODE BIOPSY; TUMOR CLASSIFICATION; TUMOR LOCALIZATION; TUMOR VOLUME;

BIOPSY, NEEDLE; BREAST NEOPLASMS; FEMALE; HUMANS; RETROSPECTIVE STUDIES; SENTINEL LYMPH NODE BIOPSY;

EID: 20844455095     PISSN: 1075122X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1075-122X.2005.21599.x     Document Type: Letter

References (3)

1. Albertini JJ, Lyman GH, Cox C, et al. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA 1996;276:1818-22.
2. Sheldon MF, Krag DN, McNally RK, et al. Limitation in gamma probe localization of the sentinel node in breast cancer patients with large excisional biopsy. J Am Coll Surg 1999;188:248-54.
3. Bass SS, Lyman GH, McCann CR, et al. Lymphatic mapping and sentinel lymph node biopsy. Breast J 1999;5:288-95.